The OBN Investment & Tax Special Interest Group (ITSIG) works to get the voice of OBN Members heard in the national and local political arena in an effort to create a more favourable fiscal environment for emerging, small and medium sized enterprises in the life sciences industry, from UK and European Governments.
Please have a look and download 'From Seed to Unicorn', our guide to the sources of funding available to life sciences companies.
The ITSIG Team
Shawn Manning, Managing Director, Akesios Associates Limited
John Harris, CEO, OBN
Bill Fleming, Finance Consultant
Matthew Frohn, Partner, Longwall Ventures
Kathy Hills, Partner - Corporate, Penningtons Manches
Huw Jones, CEO, Evgen Pharma PLC
Graham Samuel-Gibbon, Partner, Taylor Wessing
Mike Shearan, Senior Tax Manager, James Cowper Kreston
Howard Sherman, CFO, Safeguard Biosystems Holdings Ltd